STOCK TITAN

Agilent Technologies Inc. - A STOCK NEWS

Welcome to our dedicated page for Agilent Technologies news (Ticker: A), a resource for investors and traders seeking the latest updates and insights on Agilent Technologies stock.

Agilent Technologies Inc., originally spun out of Hewlett-Packard in 1999, has evolved into a leading firm in the life sciences and diagnostics sector. The company specializes in creating advanced measurement technologies that serve a vast range of customers across various industries.

The company's core business revolves around three main segments: life science and applied tools, cross lab (which includes consumables and services related to life sciences and applied tools), and diagnostics and genomics. These segments collectively cater to a broad spectrum of markets, including biopharmaceuticals, chemicals, advanced materials, clinical labs, environmental testing, forensics, food safety, academic research, and government-related organizations.

Agilent's geographical reach is extensive, with significant operations in the U.S. and China. The company is committed to addressing global trends impacting human health and the environment and continuously anticipates future scientific needs.

Agilent provides comprehensive laboratory solutions that enhance the efficiency of laboratories, from sample preparation to data interpretation and management. Their instruments, software, services, and consumables are designed to meet the most complex laboratory demands, empowering scientists and researchers worldwide to make impactful discoveries and improvements in various fields.

Recent achievements include advancements in biopharmaceutical technology, collaborations with leading research institutions, and the launch of state-of-the-art diagnostic tools. The company also emphasizes sustainable practices and innovations aimed at improving human health and environmental outcomes.

Rhea-AI Summary

Agilent Technologies Inc. (NYSE: A) has enhanced its 8700 LDIR Chemical Imaging System for microplastics analysis, introducing Clarity 1.5 software for quicker and more accurate results. This upgrade aims to tackle challenges in current microplastics studies, which are often hindered by slow analysis and method variability. The redesigned system will allow higher testing volumes, essential for understanding environmental microplastics contamination. Agilent remains committed to improving analytical solutions in food and environmental sectors, reinforcing its market leadership.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.97%
Tags
none
-
Rhea-AI Summary

Agilent Technologies Inc. (NYSE: A) announced a quarterly dividend of 21 cents per share, scheduled for payment on October 26, 2022, to shareholders on record as of October 4, 2022. The future dividends' timing and amounts will be determined by the company’s board of directors. Agilent generated revenue of $6.32 billion in fiscal 2021, employing around 17,000 people globally. This announcement underscores the company's commitment to returning value to shareholders while navigating the evolving financial landscape.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.65%
Tags
dividends
-
Rhea-AI Summary

Agilent Technologies (NYSE: A) has received Great Place to Work® Certification in 20 countries, showcasing its reputation as a leading employer. An independent survey revealed that 88% of employees view Agilent as a great workplace. The company emphasizes a culture of integrity, respect, and inclusivity, with 86% of respondents willing to recommend employment at Agilent. The certification signifies ongoing commitment to a positive employee experience, which is critical for business performance. Agilent generated $6.32 billion in revenue in fiscal 2021 and employs 17,000 people globally.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.22%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.63%
Tags
none
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.86%
Tags
none
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.65%
Tags
none
Rhea-AI Summary

Agilent Technologies Inc. (NYSE: A) has partnered with METTLER TOLEDO to enhance laboratory efficiency and accuracy in sample preparation. Their integrated solution automates the transfer of weighing results from METTLER TOLEDO's LabX Balance software to Agilent's OpenLab software, thus minimizing errors and improving workflows. This innovation aims to eliminate common transcription errors and accelerate digital transformation in labs. The collaboration was announced at Analytica 2022 in Munich and emphasizes the commitment to improving lab productivity.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.53%
Tags
none
-
Rhea-AI Summary

Agilent Technologies reported strong Q3 2022 results, with revenue of $1.72 billion, reflecting an 8% year-over-year increase. GAAP net income reached $329 million or $1.10 EPS, a 28% increase from last year. Non-GAAP net income was $401 million with $1.34 EPS, up 22%. The company has raised its full-year revenue guidance to $6.750-$6.775 billion, indicating 6.8%-7.2% growth. Expected Q4 revenue is $1.750-$1.775 billion with non-GAAP EPS of $1.38-$1.40.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.17%
Tags
-
Rhea-AI Summary

Agilent Technologies Inc. (NYSE: A) has acquired Polymer Standards Service GmbH (PSS) to enhance its offerings in polymer characterization. PSS specializes in gel permeation chromatography (GPC) and size exclusion chromatography (SEC), crucial for analyzing macromolecules. This acquisition aims to expand Agilent's product portfolio, particularly in chemical and biopharmaceutical industries. The integration will leverage Agilent’s global reach to broaden the use of PSS's technologies and products. Financial terms of the acquisition have not been disclosed.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.61%
Tags
Rhea-AI Summary

Agilent Technologies (NYSE: A) has awarded the Agilent Thought Leader Award to Professor Gerhardt Attard from University College London for his groundbreaking research in prostate cancer using innovative liquid biopsy technologies. The award will support the identification of biomarkers related to cancer progression through analysis of circulating tumor DNA. Professor Attard expressed excitement about the potential of his research to enhance diagnostic tools for cancer treatment. Agilent's commitment to funding such research highlights its ongoing investment in advancing cancer genomics and diagnostics.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.61%
Tags
none

FAQ

What is the current stock price of Agilent Technologies (A)?

The current stock price of Agilent Technologies (A) is $151.52 as of January 31, 2025.

What is the market cap of Agilent Technologies (A)?

The market cap of Agilent Technologies (A) is approximately 43.5B.

What does Agilent Technologies Inc. specialize in?

Agilent specializes in life sciences, diagnostics, and measurement technologies, providing advanced solutions and services for laboratories.

When was Agilent Technologies Inc. founded?

Agilent Technologies was spun out of Hewlett-Packard in 1999.

What are the main business segments of Agilent Technologies Inc.?

Agilent operates in three main segments: life science and applied tools, cross lab, and diagnostics and genomics.

Which industries does Agilent Technologies Inc. serve?

Agilent serves industries such as biopharmaceuticals, chemicals, advanced materials, clinical labs, environmental testing, forensics, food safety, academic research, and government organizations.

Where are Agilent Technologies Inc.'s main operations located?

Agilent's main operations are located in the U.S. and China.

What recent achievements has Agilent Technologies Inc. made?

Recent achievements include advancements in biopharmaceutical technology, collaborations with research institutions, and new diagnostic tools.

How does Agilent Technologies Inc. contribute to laboratory efficiency?

Agilent enhances laboratory efficiency through comprehensive solutions for sample preparation, data interpretation, and management.

What sustainable practices does Agilent Technologies Inc. emphasize?

Agilent focuses on innovations that improve human health and environmental outcomes, emphasizing sustainability in its practices.

Why do scientists and researchers trust Agilent Technologies Inc.?

Scientists and researchers trust Agilent for its reliable solutions that meet complex laboratory demands and enable significant insights.

What kind of global issues does Agilent Technologies Inc. address?

Agilent addresses global issues related to human health and the environment, anticipating future scientific needs.
Agilent Technologies Inc.

NYSE:A

A Rankings

A Stock Data

43.49B
284.65M
Analytical Laboratory Instrument Manufacturing
Laboratory Analytical Instruments
Link
US
SANTA CLARA